NextPlat partners with HealthWarehouse to enable 50-state prescription and OTC fulfillment; FY2025 revenue is expected to total $55 million

Reuters03-26
<a href="https://laohu8.com/S/NXPL">NextPlat</a> partners with HealthWarehouse to enable 50-state prescription and OTC fulfillment; FY2025 revenue is expected to total $55 million
  • NextPlat entered a collaboration with HealthWarehouse to enable nationwide fulfillment of prescription and over-the-counter medications to consumers across all 50 US states.
  • The arrangement allows NextPlat’s PharmcoRx division to expand prescription fulfillment beyond Florida using HealthWarehouse’s licensed, NABP-accredited digital pharmacy platform and national fulfillment infrastructure.
  • NextPlat said Florida is expected to account for more than 70% of its USD 55 million annual revenue.
  • The companies plan to integrate their platforms and support new and existing healthcare partners seeking multi-state medication access and e-commerce distribution.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment